BlackBarn Capital Partners LP
CIK
2010204
Location
NEW YORK, NY
Portfolio Value
Micro
$31,954,422
Diversification
Highly concentrated
Filing Date
Global Rank
#1,713
/ 8,578
▼ 310
Top Industry
Medical Instruments & Supplies
22.3%
3Y Alpha vs SPY
+0.3%
Period ended 3 months ago
Filed May 15, 2026 · 31d
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+56.6%
SPY
+55.8%
Annualised alpha
+0.3%
Max drawdown
−18.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
19 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
50.0%
−17.3 pts
Top 5
72.0%
−12.8 pts
Top 10
86.4%
−7.8 pts
HHI
2,700
Highly concentrated−1,933
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 52.2% | $543,862,032 |
| Healthcare | 24.8% | $258,744,673 |
| Technology | 6.8% | $71,270,600 |
| Industrials | 4.1% | $42,960,000 |
| Real Estate | 3.1% | $31,954,422 |
| Utilities | 3.0% | $31,114,800 |
| Consumer Defensive | 2.7% | $28,612,340 |
| Communication Services | 2.1% | $21,795,000 |
| Consumer Cyclical | 1.1% | $11,160,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MH | McGraw Hill, Inc. | +688,492 | 2,088,492 | $28,612,340 | |
| ABUS | Arbutus Biopharma Corp | +650,000 | 2,500,000 | $11,250,000 | |
| CCOI | Cogent Communications Holdings, Inc. | +350,000 | 1,000,000 | $18,840,000 | |
| PRVA | Privia Health Group, Inc. | +285,000 | 1,585,000 | $32,603,450 | |
| NIQ | NIQ Global Intelligence plc | +274,761 | 2,074,761 | $23,590,032 | |
| AMRX | Amneal Pharmaceuticals, Inc. | +80,000 | 1,650,000 | $20,509,500 | |
| VKTX | Viking Therapeutics, Inc. | +71,450 | 621,450 | $20,221,983 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
4 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| WRBY | Warby Parker Inc. | −2,000,000 | 1,000,000 | $21,070,000 | |
| DHC | Diversified Healthcare Trust | −1,717,727 | 4,812,413 | $31,954,422 | |
| ROIV | Roivant Sciences Ltd. | −799,183 | 2,285,117 | $63,297,740 | |
| SPY | Spdr S&P 500 ETF Trust | −700,000 | 800,000 | $520,272,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AAL | American Airlines Group Inc. | 4,000,000 | $42,960,000 | |
| VECO | Veeco Instruments Inc | 1,000,000 | $33,860,000 | |
| PLTR | Palantir Technologies Inc. | 175,000 | $25,599,000 | |
| NXPI | NXP Semiconductors N.V. | 60,000 | $11,811,600 | |
| GBTG | Global Business Travel Group, Inc. | 2,000,000 | $11,160,000 | |
| SEAT | Vivid Seats Inc. | 500,000 | $2,955,000 | |
| No positions match the current search. | ||||
1 positions ·
$31,954,422 total
· Real Estate only
· as of Mar 31, 2026
All sectors
Communication Services
Consumer Cyclical
Consumer Defensive
Healthcare
Industrials
Real Estate
Technology
Utilities
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| DHC |
Diversified Healthcare Trust
Real Estate
|
Reduced | 4,812,413 | $31,954,422 | 100.00% |